Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Front Immunol ; 15: 1382619, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38779671

RESUMO

Introduction: Antibodies against the SARS-CoV-2 spike protein are a critical immune determinant for protection against the virus. While virus neutralization is a key function of spike-specific antibodies, antibodies also mediate Fc-dependent activities that can play a role in protection or pathogenesis. Methods: This study characterized serum antibody responses elicited after two doses of heterologous adenovirus-vectored (Ad26/ Ad5) vaccines. Results: Vaccine-induced antibody binding titers and Fc-mediated functions decreased over six months, while neutralization titers remained stable. Comparison of antibody isotypes elicited after Ad26/Ad5 vs. LNP-mRNA vaccination and after infection showed that anti-spike IgG1 were dominant and produced to high levels in all groups. The Ad26/Ad5 vaccines also induced IgG4 but not IgG2 and IgG3, whereas the LNP-mRNA vaccines elicited a full Ig spectrum (IgM, IgG1-4, IgA1-2). Convalescent COVID-19 patients had mainly IgM and IgA1 alongside IgG1. Despite these differences, the neutralization potencies against early variants were similar. However, both vaccine groups had antibodies with greater Fc potencies of binding complement and Fcg receptors than the COVID-19 group. The Ad26/Ad5 group also displayed a greater potency of RBD-specific antibody-mediated cellular phagocytosis. Discussion: Antibodies with distinctive quality were induced by different vaccines and infection. The data imply the utility of different vaccine platforms to elicit antibody responses with fine-tuned Fc activities.


Assuntos
Anticorpos Neutralizantes , Anticorpos Antivirais , Vacinas contra COVID-19 , COVID-19 , Imunoglobulina G , SARS-CoV-2 , Glicoproteína da Espícula de Coronavírus , Humanos , SARS-CoV-2/imunologia , Anticorpos Antivirais/imunologia , Anticorpos Antivirais/sangue , COVID-19/imunologia , COVID-19/prevenção & controle , Vacinas contra COVID-19/imunologia , Glicoproteína da Espícula de Coronavírus/imunologia , Glicoproteína da Espícula de Coronavírus/genética , Feminino , Imunoglobulina G/imunologia , Imunoglobulina G/sangue , Anticorpos Neutralizantes/imunologia , Anticorpos Neutralizantes/sangue , Masculino , Fragmentos Fc das Imunoglobulinas/imunologia , Fragmentos Fc das Imunoglobulinas/genética , Ad26COVS1/imunologia , Adulto , Pessoa de Meia-Idade , Adenoviridae/imunologia , Adenoviridae/genética , Vetores Genéticos , Imunoglobulina A/imunologia , Imunoglobulina A/sangue
2.
Rev. argent. ultrason ; 6(3): 210-213, sept. 2007. ilus
Artigo em Espanhol | LILACS | ID: lil-506136

RESUMO

El embarazo gemelar implica un mayor riesgo de complicaciones fetales y maternas, que deben investigarse mediante un control prenatal estricto. Algunas son las anomalías congénitas estructurales, como las cromosomopatías y el síndrome de transfusión feto-fetal. La ecografía de las semanas 11-13, 6 permite estimar el riesgo de manifestación de algunas de estas complicaciones, a fin de poder realizar el algoritmo diagnóstico correcto.


Assuntos
Humanos , Gravidez , Complicações na Gravidez/diagnóstico , Complicações na Gravidez , Doenças Fetais/diagnóstico , Doenças Fetais , Gravidez Múltipla , Ultrassonografia Pré-Natal/instrumentação , Ultrassonografia Pré-Natal
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA